Trial intelligence / Profile preview

JNS013 in Chronic Pain (OA or LBP)

NCT00736853Phase 3Completed

Sponsor
Janssen Pharmaceutical
Start
Jun 2008
Primary completion
Jan 2009
Modality
Irreversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of tramadol hydrochloride + acetaminophen in chronic pain, sponsored by Janssen Pharmaceutical. Started Jun 2008; status: completed.

02

Drugs

tramadol hydrochloride + acetaminophen
03

Conditions

chronic pain

Beyond the preview

Go deeper on NCT00736853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00736853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call